Table 1.

Associations of miR-27a and SFRP1 protein expressions with clinicopathologic features of GC patients

Clinicopathologic feature	Case	MiR-27a	P	SFRP1			P
				Positive	Negative	Positive rate
Age			0.107				0.542
< 60	189	1.91 ± 0.24		135	54	71.43%
≥ 60	84	1.86 ± 0.22		63	21	75.00%
Gender			0.374				0.019
Male	147	1.88 ± 0.24		98	49	66.67%
Female	126	1.91 ± 0.23		100	26	79.37%
Lymph node metastasis			0.003				0.023
Yes	168	1.93 ± 0.23		130	38	77.38%
No	105	1.84 ± 0.24		68	37	64.76%
Tumor differentiation			0.01				0.175
Moderate-high	120	1.85 ± 0.26		92	28	76.67%
Low-non	153	1.93 ± 0.20		106	47	69.28%
TNM stage			< 0.01				0.174
I-II	142	1.84 ± 0.24		108	34	76.06%
III-IV	131	1.96 ± 0.21		90	41	68.70%

Note: miR-27a, microRNA-27a, SFRP1, secreted frizzled-related protein 1, GC, gastric cancer; TNM, tumor-node-metastasis.